| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/29/2001 | EP1126845A2 New use of immunosuppressants for mmp-mediated diseases |
| 08/29/2001 | EP1126841A1 Method of treating migraines and pharmaceutical compositions |
| 08/29/2001 | EP1126840A1 5ht(1) receptor agonists and metoclopramide for the treatment of migraine |
| 08/29/2001 | EP1126839A1 Substituted phenethylsulfones and method of reducing tnf alpha levels |
| 08/29/2001 | EP1126838A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 08/29/2001 | EP1126836A1 Benzamide potassium channel inhibitors |
| 08/29/2001 | EP1126834A1 Analgesic regimen |
| 08/29/2001 | EP1126830A1 Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents |
| 08/29/2001 | EP1126827A2 Controlled delivery of active agents |
| 08/29/2001 | EP1126826A1 Multiparticulate modified release composition |
| 08/29/2001 | EP1054682B1 Use of hyperforin and hyperforin-containing extracts in the treatment and prophylaxis of dementing diseases |
| 08/29/2001 | EP0876141B1 Preparations of non-steroidal analgesics |
| 08/29/2001 | EP0809624B1 Alkylcarboxy amino acids-modulators of the kainate receptor |
| 08/29/2001 | EP0751709B1 Use of bcl-2 for the manufacture of medicaments for the therapeutic treatment and prevention of diseases |
| 08/29/2001 | CN1310765A Mutant herpes simplex viruses and uses thereof |
| 08/29/2001 | CN1310718A Heterocyclic compound as inhibitors of rotamase enzymes |
| 08/29/2001 | CN1310716A Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 08/29/2001 | CN1310709A N.N-substituted cyclic amine derivatives |
| 08/29/2001 | CN1310707A Novel 2,3,3A,4,9,9A hexahydro-8-hydroxy-1H-benz[f] indoles, a method for the production thereof, and their use as medicaments |
| 08/29/2001 | CN1310622A The use of valproic acid analog for the treatment and prevention of migraine and affective illness |
| 08/29/2001 | CN1310618A Inhibition of binding of Hox and homeodomain containing proteins and uses thereof |
| 08/29/2001 | CN1310180A New compound |
| 08/29/2001 | CN1310020A Medicine for preventing and treating radiation damage of central nervous system |
| 08/29/2001 | CN1310017A Chinese patent medicine for stopping pain and abstaining from drugs |
| 08/29/2001 | CN1310014A Lumbago treating Chinese medicine |
| 08/29/2001 | CN1309979A Chinese medicine Tangzhi'an for treating peripheral nerve lesion of diabetes |
| 08/29/2001 | CN1309968A Pharmaceutical application of froctose biphosphate magnesium |
| 08/29/2001 | CN1309963A Method for treating migraine symptom |
| 08/29/2001 | CN1070176C 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceuticals |
| 08/28/2001 | US6281376 Therapeutic compound—fatty acid conjugates |
| 08/28/2001 | US6281360 Reacting imidazopyridine compound with glyoxylic acid |
| 08/28/2001 | US6281352 Antiinflammatory agents |
| 08/28/2001 | US6281332 Hedgehog-derived polypeptides |
| 08/28/2001 | US6281246 Pharmaceutical composition with sotalol combination and their use in treatment of cardiac ailments |
| 08/28/2001 | US6281243 Derivatives of azetidine and pyrrolidine |
| 08/28/2001 | US6281220 Pyrrolo(3,2-d)pyrimidin-4-amines and pyrrolo(3,2-b)pyridin-4-amines, and their use as antagonists of corticotropin-releasing factor |
| 08/28/2001 | US6281218 Benzimidazolone derivatives having mixed serotonin and dopamine receptors affinity |
| 08/28/2001 | US6281216 2-aminoquinoline derivatives having d4-agonistic activity |
| 08/28/2001 | US6281214 Biphenyl derivatives |
| 08/28/2001 | US6281207 Treatment of movement disorders by administration of mirtazapine |
| 08/28/2001 | US6280971 Polynucleotide associated with detection of staphylococcus; for use in screening bactericides |
| 08/28/2001 | US6280968 Human PEC-60-like protein and DNA encoding the same |
| 08/28/2001 | US6280953 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| 08/28/2001 | US6280777 Soya extract, process for its preparation and pharmaceutical composition |
| 08/28/2001 | US6280761 Nicotine lozenge |
| 08/28/2001 | US6280736 Stable extract of Hypericum perforatum L.,process for preparing the same and pharmaceutical compositions |
| 08/28/2001 | US6280732 Administering intracerebrally al-1 immunoadhesin comprising mature al-1 polypeptide having specified amino acid sequence in amount effective to activate autophosphorylation of rek7 |
| 08/28/2001 | CA2217888C Triacetin as a transdermal penetration enhancer |
| 08/28/2001 | CA2107552C Use of deprenyl to maintain, prevent loss, or recover nerve cell function |
| 08/28/2001 | CA2042113C Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors |
| 08/28/2001 | CA2015996C Bis-(1h-indol-3-yl)-maleinimide derivatives and their use as pharmaceuticals |
| 08/23/2001 | WO2001061009A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001061008A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001060857A2 Compositions useful for regulating parkin gene activity |
| 08/23/2001 | WO2001060844A2 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 08/23/2001 | WO2001060835A1 Purine derivatives |
| 08/23/2001 | WO2001060826A2 SUCCINOYLAMINO CARBOCYCLES AND HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 08/23/2001 | WO2001060821A1 Novel biarylcarboxamides |
| 08/23/2001 | WO2001060819A1 Novel isoxazole and thiazole compounds and use thereof as drugs |
| 08/23/2001 | WO2001060816A1 Kinase inhibitors |
| 08/23/2001 | WO2001060809A1 6-substituted-4,5-epoxy-6-hydroxy-2-cyclohexen-1-one derivatives and intermediates in the production thereof |
| 08/23/2001 | WO2001060808A1 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors |
| 08/23/2001 | WO2001060807A1 Aryloxyacetic acids for diabetes and lipid disorders |
| 08/23/2001 | WO2001060806A2 Substituted arylpyrazines |
| 08/23/2001 | WO2001060802A1 4-imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use as alpha-1a agonists |
| 08/23/2001 | WO2001060798A1 Amine derivatives for the treatment of apoptosis |
| 08/23/2001 | WO2001060786A1 Aminoalcohol derivatives |
| 08/23/2001 | WO2001060784A1 Aniline-derived ligands for the thyroid receptor |
| 08/23/2001 | WO2001060414A2 Genetic modification of the lung as a portal for gene delivery |
| 08/23/2001 | WO2001060409A1 Improved paste formulations |
| 08/23/2001 | WO2001060397A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules |
| 08/23/2001 | WO2001060392A1 Oral, nasal and pulmonary dosage formualtions of copolymer 1 |
| 08/23/2001 | WO2001060381A1 Nucleoside analogs with carboxamidine-modified bicyclic base |
| 08/23/2001 | WO2001060379A1 Nucleoside analogs with carboxamidine modified monocyclic base |
| 08/23/2001 | WO2001060375A2 Use of 7alpha-hydroxy-estradiol, 7alpha-hydroxy-dehydroepiandrosterone and 7alpha-hydroxy-pregnenolone derivatives for treating acute cellular degeneration |
| 08/23/2001 | WO2001060374A1 Use of paullone derivatives for making medicines |
| 08/23/2001 | WO2001060371A1 Use of a compound for preparing a drug |
| 08/23/2001 | WO2001060364A1 Method for reducing or eliminating smoking |
| 08/23/2001 | WO2001060349A2 Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof. |
| 08/23/2001 | WO2001024807A3 Method for calming human beings using personal care compositions |
| 08/23/2001 | WO2001024764A3 Cell targeting compositions and methods of using the same |
| 08/23/2001 | WO2001013903A3 Treatment of restless leg syndrome with a combination of clonidine and opioid |
| 08/23/2001 | WO2001013902A3 Combination of active agents, said combination containing clonidine and pramipexol |
| 08/23/2001 | WO2001012775A3 25 human secreted proteins |
| 08/23/2001 | WO2001010816A3 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 08/23/2001 | WO2001007436A3 Substituted oxoazaheterocyclyl compounds |
| 08/23/2001 | WO2001004116A3 Neurotrophic pyrrolidines and piperidines, and related compositions containing them |
| 08/23/2001 | WO2000071520A3 Aryl substituted alkylamines capable of activating nicotinic cholinergic receptors |
| 08/23/2001 | WO2000044364A3 P53 inhibitors and their use for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant |
| 08/23/2001 | US20010016661 Indolealkanoic acid derivatives inhibits aldose reductase and useful for treating chronic complication associated with diabetes mellitus including diabetic cataracts, retinopathy, nephropathy and neuropathy |
| 08/23/2001 | US20010016596 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 08/23/2001 | US20010016590 Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol |
| 08/23/2001 | US20010016586 Use of organic compounds |
| 08/23/2001 | US20010016584 Synergistic mixture of acetaminophen and buspirone |
| 08/23/2001 | US20010016579 Serotonin 5-HT, receptor partial activator |
| 08/23/2001 | US20010016576 Administering pyrimidine nucleotide precursor where respiratory chain dysfunction is caused by mutation, deletion, or rearrangement of mitochondrial DNA, cytotoxic cancer chemotherapy agents, aging |
| 08/23/2001 | US20010016570 Bone disorders |
| 08/23/2001 | US20010016336 Genetic engineered polypeptide |
| 08/23/2001 | US20010016197 Cultivating a fungi of the basidiomycetes in a submerged culture on nutrient media, isolating the biomass of edible mushrooms from the culture broth, and drying at a range of 40-45 degrees celsius |
| 08/23/2001 | CA2651825A1 Substituted arylpyrazines |